Artificial intelligence in healthcare
Artificial intelligence in healthcare is the use of complex algorithms and software in other words artificial intelligence (AI) to emulate human cognition in the analysis, interpretation, and comprehension of complicated medical and healthcare data. Specifically, AI is the ability of computer algorithms to approximate conclusions without direct human input.
What distinguishes AI technology from traditional technologies in health care is the ability to gain information, process it and give a well-defined output to the end-user. AI does this through machine learning algorithms and deep learning. These algorithms can recognize patterns in behavior and create their own logic. In order to reduce the margin of error, AI algorithms need to be tested repeatedly. AI algorithms behave differently from humans in two ways: (1) algorithms are literal: if you set a goal, the algorithm can't adjust itself and only understand what it has been told explicitly, (2) and some deep learning algorithms are black boxes; algorithms can predict with extreme precision, but not the cause or the why.
The primary aim of health-related AI applications is to analyze relationships between prevention or treatment techniques and patient outcomes. AI programs have been developed and applied to practices such as diagnosis processes, treatment protocol development, drug development, personalized medicine, and patient monitoring and care. Medical institutions such as The Mayo Clinic, Memorial Sloan Kettering Cancer Center, and the British National Health Service, have developed AI algorithms for their departments. Large technology companies such as IBM and Google, have also developed AI algorithms for healthcare. Additionally, hospitals are looking to AI software to support operational initiatives that increase cost saving, improve patient satisfaction, and satisfy their staffing and workforce needs. Companies are developing predictive analytics solutions[buzzword] that help healthcare managers improve business operations through increasing utilization, decreasing patient boarding, reducing length of stay and optimizing staffing levels.
Research in the 1960s and 1970s produced the first problem-solving program, or expert system, known as Dendral. While it was designed for applications in organic chemistry, it provided the basis for a subsequent system MYCIN, considered one of the most significant early uses of artificial intelligence in medicine. MYCIN and other systems such as INTERNIST-1 and CASNET did not achieve routine use by practitioners, however.
The 1980s and 1990s brought the proliferation of the microcomputer and new levels of network connectivity. During this time, there was a recognition by researchers and developers that AI systems in healthcare must be designed to accommodate the absence of perfect data and build on the expertise of physicians. Approaches involving fuzzy set theory, Bayesian networks, and artificial neural networks, have been applied to intelligent computing systems in healthcare.
Medical and technological advancements occurring over this half-century period that have enabled the growth healthcare-related applications of AI include:
- Improvements in computing power resulting in faster data collection and data processing
- Growth of genomic sequencing databases
- Widespread implementation of electronic health record systems
- Improvements in natural language processing and computer vision, enabling machines to replicate human perceptual processes
- Enhanced the precision of robot-assisted surgery
- Improvements in deeplearning techniques and data logs in rare diseases
Various specialties in medicine have shown an increase in research regarding AI.
The ability to interpret imaging results with radiology may aid clinicians in detecting a minute change in an image that a clinician might accidentally miss. A study at Stanford created an algorithm that could detect pneumonia at that specific site, in those patients involved, with a better average F1 metric (a statistical metric based on accuracy and recall), than the radiologists involved in that trial. Several companies (icometrix, QUIBIM, Robovision, ...) have popped up that offer AI platforms for uploading images to. There are also vendor-neutral systems like UMC Utrecht's IMAGR AI. These platforms are trainable through deep learning to detect a wide range of specific diseases and disorders. The radiology conference Radiological Society of North America has implemented presentations on AI in imaging during its annual meeting. The emergence of AI technology in radiology is perceived as a threat by some specialists, as the technology can achieve improvements in certain statistical metrics in isolated cases, as opposed to specialists.
Recent advances have suggested the use of AI to describe and evaluate the outcome of maxillo-facial surgery or the assessment of cleft palate therapy in regard to facial attractiveness or age appearance.
In 2018, a paper published in the journal Annals of Oncology mentioned that skin cancer could be detected more accurately by an artificial intelligence system (which used a deep learning convolutional neural network) than by dermatologists. On average, the human dermatologists accurately detected 86.6% of skin cancers from the images, compared to 95% for the CNN machine.
In July 2020 it was reported that an AI algorithm by the University of Pittsburgh achieves the highest accuracy to date in identifying prostate cancer, with 98% sensitivity and 97% specificity.
In psychiatry, AI applications are still in a phase of proof-of-concept. Areas where the evidence is widening quickly include chatbots, conversational agents that imitate human behaviour and which have been studied for anxiety and depression.
Challenges include the fact that many applications in the field are developed and proposed by private corporations, such as the screening for suicidal ideation implemented by Facebook in 2017. Such applications outside the healthcare system raise various professional, ethical and regulatory questions.
Primary care has become one key development area for AI technologies. AI in primary care has been used for supporting decision making, predictive modelling, and business analytics. Despite the rapid advances in AI technologies, general practitioners' view on the role of AI in primary care is very limited–mainly focused on administrative and routine documentation tasks.
There are many diseases and there also many ways that AI has been used to efficiently and accurately diagnose them. Some of the diseases that are the most notorious such as Diabetes, and Cardiovascular Disease (CVD) which are both in the top ten for causes of death worldwide have been the basis behind a lot of the research/testing to help get an accurate diagnosis. Due to such a high mortality rate being associated with these diseases there have been efforts to integrate various methods in helping get accurate diagnosis’.
An article by Jiang, et al. (2017) demonstrated that there are several types of AI techniques that have been used for a variety of different diseases. Some of these techniques discussed by Jiang, et al. include: Support vector machines, neural networks, Decision trees, and many more. Each of these techniques is described as having a “training goal” so “classifications agree with the outcomes as much as possible…”.
To demonstrate some specifics for disease diagnosis/classification there are two different techniques used in the classification of these diseases include using “Artificial Neural Networks (ANN) and Bayesian Networks (BN)”. From a review of multiple different papers within the timeframe of 2008-2017 observed within them which of the two techniques were better. The conclusion that was drawn was that “the early classification of these diseases can be achieved developing machine learning models such as Artificial Neural Network and Bayesian Network.” Another conclusion Alic, et al. (2017) was able to draw was that between the two ANN and BN that ANN was better and could more accurately classify diabetes/CVD with a mean accuracy in “both cases (87.29 for diabetes and 89.38 for CVD).
The increase of telemedicine, has shown the rise of possible AI applications. The ability to monitor patients using AI may allow for the communication of information to physicians if possible disease activity may have occurred. A wearable device may allow for constant monitoring of a patient and also allow for the ability to notice changes that may be less distinguishable by humans.
Electronic health recordsEdit
Electronic health records are crucial to the digitalization and information spread of the healthcare industry. However, logging all of this data comes with its own problems like cognitive overload and burnout for users. EHR developers are now automating much of the process and even starting to use natural language processing (NLP) tools to improve this process. One study conducted by the Centerstone research institute found that predictive modeling of EHR data has achieved 70–72% accuracy in predicting individualized treatment response at baseline. Meaning using an AI tool that scans EHR data. It can pretty accurately predict the course of disease in a person.
Improvements in natural language processing led to the development of algorithms to identify drug-drug interactions in medical literature. Drug-drug interactions pose a threat to those taking multiple medications simultaneously, and the danger increases with the number of medications being taken. To address the difficulty of tracking all known or suspected drug-drug interactions, machine learning algorithms have been created to extract information on interacting drugs and their possible effects from medical literature. Efforts were consolidated in 2013 in the DDIExtraction Challenge, in which a team of researchers at Carlos III University assembled a corpus of literature on drug-drug interactions to form a standardized test for such algorithms. Competitors were tested on their ability to accurately determine, from the text, which drugs were shown to interact and what the characteristics of their interactions were. Researchers continue to use this corpus to standardize the measurement of the effectiveness of their algorithms.
Other algorithms identify drug-drug interactions from patterns in user-generated content, especially electronic health records and/or adverse event reports. Organizations such as the FDA Adverse Event Reporting System (FAERS) and the World Health Organization's VigiBase allow doctors to submit reports of possible negative reactions to medications. Deep learning algorithms have been developed to parse these reports and detect patterns that imply drug-drug interactions.
Creation of new drugsEdit
DSP-1181, a molecule of the drug for OCD (obsessive-compulsive disorder) treatment, was invented by artificial intelligence through joint efforts of Exscientia (British start-up) and Sumitomo Dainippon Pharma (Japanese pharmaceutical firm). The drug development took a single year, while pharmaceutical companies usually spend about five years on similar projects. DSP-1181 was accepted for a human trial.
In September 2019 Insilico Medicine reports the creation, via artificial intelligence, of six novel inhibitors of the DDR1 gene, a kinase target implicated in fibrosis and other diseases. The system, known as Generative Tensorial Reinforcement Learning (GENTRL), designed the new compounds in 21 days, with a lead candidate tested and showing positive results in mice.
The same month Canadian company Deep Genomics announces that its AI-based drug discovery platform has identified a target and drug candidate for Wilson's disease. The candidate, DG12P1, is designed to correct the exon-skipping effect of Met645Arg, a genetic mutation affecting the ATP7B copper-binding protein.
The subsequent motive of large based health companies merging with other health companies, allow for greater health data accessibility. Greater health data may allow for more implementation of AI algorithms.
A large part of industry focus of implementation of AI in the healthcare sector is in the clinical decision support systems. As the amount of data increases, AI decision support systems become more efficient. Numerous companies are exploring the possibilities of the incorporation of big data in the health care industry.
The following are examples of large companies that have contributed to AI algorithms for use in healthcare:
- IBM's Watson Oncology is in development at Memorial Sloan Kettering Cancer Center and Cleveland Clinic. IBM is also working with CVS Health on AI applications in chronic disease treatment and with Johnson & Johnson on analysis of scientific papers to find new connections for drug development. In May 2017, IBM and Rensselaer Polytechnic Institute began a joint project entitled Health Empowerment by Analytics, Learning and Semantics (HEALS), to explore using AI technology to enhance healthcare.
- Microsoft's Hanover project, in partnership with Oregon Health & Science University's Knight Cancer Institute, analyzes medical research to predict the most effective cancer drug treatment options for patients. Other projects include medical image analysis of tumor progression and the development of programmable cells.
- Google's DeepMind platform is being used by the UK National Health Service to detect certain health risks through data collected via a mobile app. A second project with the NHS involves analysis of medical images collected from NHS patients to develop computer vision algorithms to detect cancerous tissues.
- Tencent is working on several medical systems and services. These include AI Medical Innovation System (AIMIS), an AI-powered diagnostic medical imaging service; WeChat Intelligent Healthcare; and Tencent Doctorwork
- Intel's venture capital arm Intel Capital recently invested in startup Lumiata which uses AI to identify at-risk patients and develop care options.
- Kheiron Medical developed deep learning software to detect breast cancers in mammograms.
- Fractal Analytics has incubated Qure.ai which focuses on using deep learning and AI to improve radiology and speed up the analysis of diagnostic x-rays.
Digital consultant apps like Babylon Health's GP at Hand, Ada Health, AliHealth Doctor You, KareXpert and Your.MD use AI to give medical consultation based on personal medical history and common medical knowledge. Users report their symptoms into the app, which uses speech recognition to compare against a database of illnesses. Babylon then offers a recommended action, taking into account the user's medical history. Entrepreneurs in healthcare have been effectively using seven business model archetypes to take AI solution[buzzword] to the marketplace. These archetypes depend on the value generated for the target user (e.g. patient focus vs. healthcare provider and payer focus) and value capturing mechanisms (e.g. providing information or connecting stakeholders).
IFlytek launched a service robot “Xiao Man”, which integrated artificial intelligence technology to identify the registered customer and provide personalized recommendations in medical areas. It also works in the field of medical imaging. Similar robots are also being made by companies such as UBTECH ("Cruzr") and Softbank Robotics ("Pepper").
The use of AI is predicted to decrease medical costs as there will be more accuracy in diagnosis and better predictions in the treatment plan as well as more prevention of disease.
Other future uses for AI include Brain-computer Interfaces (BCI) which are predicted to help those with trouble moving, speaking or with a spinal cord injury. The BCIs will use AI to help these patients move and communicate by decoding neural activates.
As technology evolves and is implemented in more workplaces, many fear that their jobs will be replaced by robots or machines. The U.S. News Staff (2018) writes that in the near future, doctors who utilize AI will “win out” over the doctors who don't. AI will not replace healthcare workers but instead, allow them more time for bedside cares. AI may avert healthcare worker burn out and cognitive overload. Overall, as Quan-Haase (2018) says, technology “extends to the accomplishment of societal goals, including higher levels of security, better means of communication over time and space, improved health care, and increased autonomy” (p. 43). As we adapt and utilize AI into our practice we can enhance our care to our patients resulting in greater outcomes for all.
Expanding care to developing nationsEdit
With an increase in the use of AI, more care may become available to those in developing nations. AI continues to expand in its abilities and as it is able to interpret radiology, it may be able to diagnose more people with the need for fewer doctors as there is a shortage in many of these nations. The goal of AI is to teach others in the world, which will then lead to improved treatment and eventually greater global health. Using AI in developing nations who do not have the resources will diminish the need for outsourcing and can use AI to improve patient care. For example, Natural language processing, and machine learning are being used for guiding cancer treatments in places such as Thailand, China, and India. Researchers trained an AI application to use NLP to mine through patient records, and provide treatment. The ultimate decision made by the AI application agreed with expert decisions 90% of the time.
While research on the use of AI in healthcare aims to validate its efficacy in improving patient outcomes before its broader adoption, its use may nonetheless introduce several new types of risk to patients and healthcare providers, such as algorithmic bias, Do not resuscitate implications, and other machine morality issues. These challenges of the clinical use of AI has brought upon potential need for regulations.
Currently no regulations exist specifically for the use of AI in healthcare. In May 2016, the White House announced its plan to host a series of workshops and formation of the National Science and Technology Council (NSTC) Subcommittee on Machine Learning and Artificial Intelligence. In October 2016, the group published The National Artificial Intelligence Research and Development Strategic Plan, outlining its proposed priorities for Federally-funded AI research and development (within government and academia). The report notes a strategic R&D plan for the subfield of health information technology is in development stages.
The only agency that has expressed concern is the FDA. Bakul Patel, the Associate Center Director for Digital Health of the FDA, is quoted saying in May 2017.
“We're trying to get people who have hands-on development experience with a product's full life cycle. We already have some scientists who know artificial intelligence and machine learning, but we want complementary people who can look forward and see how this technology will evolve.”
The joint ITU-WHO Focus Group on Artificial Intelligence for Health (FG-AI4H) has built a platform for the testing and benchmarking of AI applications in health domain. As of November 2018, eight use cases are being benchmarked, including assessing breast cancer risk from histopathological imagery, guiding anti-venom selection from snake images, and diagnosing skin lesions.
- Artificial intelligence
- Glossary of artificial intelligence
- Full body scanner (ie Dermascanner, ...)
- Clinical decision support system
- Computer-aided diagnosis
- Computer-aided simple triage
- Google DeepMind
- IBM Watson Health
- Medical image computing
- Michal Rosen-Zvi
- Speech recognition software in healthcare
- The MICCAI Society
- Luca M, Kleinberg J, Mullainathan S (January–February 2016). "Algorithms Need Managers, Too". Harvard Business Review. Retrieved 2018-10-08.
- Coiera E (1997). Guide to medical informatics, the Internet and telemedicine. Chapman & Hall, Ltd.
- Power B (19 March 2015). "Artificial Intelligence Is Almost Ready for Business". Massachusetts General Hospital.
- Bahl M, Barzilay R, Yedidia AB, Locascio NJ, Yu L, Lehman CD (March 2018). "High-Risk Breast Lesions: A Machine Learning Model to Predict Pathologic Upgrade and Reduce Unnecessary Surgical Excision". Radiology. 286 (3): 810–818. doi:10.1148/radiol.2017170549. PMID 29039725.
- Bloch-Budzier S (22 November 2016). "NHS using Google technology to treat patients".
- Lorenzetti L (5 April 2016). "Here's How IBM Watson Health is Transforming the Health Care Industry". Fortune.
- Kent J (2018-08-08). "Providers Embrace Predictive Analytics for Clinical, Financial Benefits". HealthITAnalytics. Retrieved 2019-01-16.
- Lee K (4 January 2016). "Predictive analytics in healthcare helps improve OR utilization". SearchHealthIT. Retrieved 2019-01-16.
- Lindsay RK, Buchanan BG, Feigenbaum EA, Lederberg J (1993). "DENDRAL: a case study of the first expert system for scientific hypothesis formation". Artificial Intelligence. 61 (2): 209–261. doi:10.1016/0004-3702(93)90068-m. hdl:2027.42/30758.
- Clancey WJ, Shortliffe EH (1984). Readings in medical artificial intelligence: the first decade. Addison-Wesley Longman Publishing Co., Inc.
- Bruce G, Buchanan BG, Shortliffe ED (1984). Rule-based expert systems: the MYCIN experiments of the Stanford Heuristic Programming Project.
- Duda RO, Shortliffe EH (April 1983). "Expert Systems Research". Science. New York, N.Y. 220 (4594): 261–8. Bibcode:1983Sci...220..261D. doi:10.1126/science.6340198. PMID 6340198.
- Miller RA (1994). "Medical diagnostic decision support systems--past, present, and future: a threaded bibliography and brief commentary". Journal of the American Medical Informatics Association. 1 (1): 8–27. doi:10.1136/jamia.1994.95236141. PMC 116181. PMID 7719792.
- Adlassnig KP (July 1980). "A fuzzy logical model of computer-assisted medical diagnosis" (PDF). Methods of Information in Medicine. 19 (3): 141–8. doi:10.1055/s-0038-1636674. PMID 6997678.
- Reggia JA, Peng Y (September 1987). "Modeling diagnostic reasoning: a summary of parsimonious covering theory". Computer Methods and Programs in Biomedicine. 25 (2): 125–34. doi:10.1016/0169-2607(87)90048-4. PMC 2244953. PMID 3315427.
- Baxt WG (December 1991). "Use of an artificial neural network for the diagnosis of myocardial infarction". Annals of Internal Medicine. 115 (11): 843–8. doi:10.7326/0003-4819-115-11-843. PMID 1952470.
- Maclin PS, Dempsey J, Brooks J, Rand J (February 1991). "Using neural networks to diagnose cancer". Journal of Medical Systems. 15 (1): 11–9. doi:10.1007/bf00993877. PMID 1748845. S2CID 10189561.
- Koomey J, Berard S, Sanchez M, Wong H (March 2010). "Implications of historical trends in the electrical efficiency of computing". IEEE Annals of the History of Computing. 33 (3): 46–54. CiteSeerX 10.1.1.323.9505. doi:10.1109/MAHC.2010.28. S2CID 8305701.
- Barnes B, Dupré J (2009). Genomes and what to make of them. University of Chicago Press.[page needed]
- Jha AK, DesRoches CM, Campbell EG, Donelan K, Rao SR, Ferris TG, Shields A, Rosenbaum S, Blumenthal D (April 2009). "Use of electronic health records in U.S. hospitals". The New England Journal of Medicine. 360 (16): 1628–38. doi:10.1056/NEJMsa0900592. PMID 19321858. S2CID 19914056.
- Banko M, Brill E (July 2001). "Scaling to very very large corpora for natural language disambiguation]" (PDF). Proceedings of the 39th Annual Meeting on Association for Computational Linguistics. Association for Computational Linguistics: 26–33.
- Dougherty G (2009). Digital image processing for medical applications. Cambridge University Press.
- "Artificial Intelligence and Machine Learning for Healthcare". Sigmoidal. 21 December 2017.
- Rajpurkar P, Irvin J, Zhu K, Yang B, Mehta H, Duan T, Ding D, Bagul A, Langlotz C, Shpanskaya K, Lungren MP (2017-11-14). "CheXNet: Radiologist-Level Pneumonia Detection on Chest X-Rays with Deep Learning". arXiv:1711.05225 [cs.CV].
- Rouger M. "The cost of AI in radiology: is it really worth it?". AI Blog. European Society of Radiology (ESR).
- "AI platform workings". Robovision.
- "Robovision (Flanders) deploys AI for COVID-19 testing". Cite journal requires
- Li L, Qin L, Xu Z, Yin Y, Wang X, et al. (March 2020). "Artificial Intelligence Distinguishes COVID-19 from Community Acquired Pneumonia on Chest CT". Radiology. 296 (2): E65–E71. doi:10.1148/radiol.2020200905. PMC 7233473. PMID 32191588.
- Chockley K, Emanuel E (December 2016). "The End of Radiology? Three Threats to the Future Practice of Radiology". Journal of the American College of Radiology. 13 (12 Pt A): 1415–1420. doi:10.1016/j.jacr.2016.07.010. PMID 27652572.
- Jha S, Topol EJ (December 2016). "Adapting to Artificial Intelligence: Radiologists and Pathologists as Information Specialists". JAMA. 316 (22): 2353–2354. doi:10.1001/jama.2016.17438. PMID 27898975.
- Patcas R, Bernini DA, Volokitin A, Agustsson E, Rothe R, Timofte R (January 2019). "Applying artificial intelligence to assess the impact of orthognathic treatment on facial attractiveness and estimated age". International Journal of Oral and Maxillofacial Surgery. 48 (1): 77–83. doi:10.1016/j.ijom.2018.07.010. PMID 30087062.
- Patcas R, Timofte R, Volokitin A, Agustsson E, Eliades T, Eichenberger M, Bornstein MM (August 2019). "Facial attractiveness of cleft patients: a direct comparison between artificial-intelligence-based scoring and conventional rater groups". European Journal of Orthodontics. 41 (4): 428–433. doi:10.1093/ejo/cjz007. PMID 30788496. S2CID 73507799.
- "Computer learns to detect skin cancer more accurately than doctors". The Guardian. 29 May 2018.
- Kobie, Nicole (1 January 2020). "DeepMind's new AI can spot breast cancer just as well as your doctor". Wired UK. Wired. Retrieved 1 January 2020.
- McKinney, Scott Mayer; Sieniek, Marcin; Godbole, Varun; Godwin, Jonathan; Antropova, Natasha; Ashrafian, Hutan; Back, Trevor; Chesus, Mary; Corrado, Greg C.; Darzi, Ara; Etemadi, Mozziyar; Garcia-Vicente, Florencia; Gilbert, Fiona J.; Halling-Brown, Mark; Hassabis, Demis; Jansen, Sunny; Karthikesalingam, Alan; Kelly, Christopher J.; King, Dominic; Ledsam, Joseph R.; Melnick, David; Mostofi, Hormuz; Peng, Lily; Reicher, Joshua Jay; Romera-Paredes, Bernardino; Sidebottom, Richard; Suleyman, Mustafa; Tse, Daniel; Young, Kenneth C.; et al. (1 January 2020). "International evaluation of an AI system for breast cancer screening". Nature. 577 (7788): 89–94. Bibcode:2020Natur.577...89M. doi:10.1038/s41586-019-1799-6. PMID 31894144. S2CID 209523468.
- "Artificial intelligence identifies prostate cancer with near-perfect accuracy". EurekAlert!. 27 July 2020. Retrieved 29 July 2020.
- Pantanowitz, Liron; Quiroga-Garza, Gabriela M.; Bien, Lilach; Heled, Ronen; Laifenfeld, Daphna; Linhart, Chaim; Sandbank, Judith; Albrecht Shach, Anat; Shalev, Varda; Vecsler, Manuela; Michelow, Pamela; Hazelhurst, Scott; Dhir, Rajiv (1 August 2020). "An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment study". The Lancet Digital Health. 2 (8): e407–e416. doi:10.1016/S2589-7500(20)30159-X. ISSN 2589-7500. Retrieved 17 August 2020.
- Graham, Sarah; Depp, Colin; Lee, Ellen E.; Nebeker, Camille; Tu, Xin; Kim, Ho-Cheol; Jeste, Dilip V. (2019-11-07). "Artificial Intelligence for Mental Health and Mental Illnesses: an Overview". Current Psychiatry Reports. 21 (11): 116. doi:10.1007/s11920-019-1094-0. ISSN 1535-1645. PMC 7274446. PMID 31701320.
- Fulmer, Russell; Joerin, Angela; Gentile, Breanna; Lakerink, Lysanne; Rauws, Michiel (2018-12-13). "Using Psychological Artificial Intelligence (Tess) to Relieve Symptoms of Depression and Anxiety: Randomized Controlled Trial". JMIR Mental Health. 5 (4): e64. doi:10.2196/mental.9782. ISSN 2368-7959. PMC 6315222. PMID 30545815.
- Coppersmith, Glen; Leary, Ryan; Crutchley, Patrick; Fine, Alex (January 2018). "Natural Language Processing of Social Media as Screening for Suicide Risk". Biomedical Informatics Insights. 10: 117822261879286. doi:10.1177/1178222618792860. ISSN 1178-2226. PMC 6111391. PMID 30158822.
- Brunn, Matthias; Diefenbacher, Albert; Courtet, Philippe; Genieys, William (2020-05-18). "The Future is Knocking: How Artificial Intelligence Will Fundamentally Change Psychiatry". Academic Psychiatry. 44 (4): 461–466. doi:10.1007/s40596-020-01243-8. ISSN 1545-7230. PMID 32424706. S2CID 218682746.
- Mistry, Pritesh (1 September 2019). "Artificial intelligence in primary care". British Journal of General Practice. 69 (686): 422–423. doi:10.3399/bjgp19X705137. PMC 6715470. PMID 31467001.
- Blease, Charlotte; Kaptchuk, Ted J; Bernstein, Michael H; Mandl, Kenneth D; Halamka, John D; DesRoches, Catherine M (20 March 2019). "Artificial Intelligence and the Future of Primary Care: Exploratory Qualitative Study of UK General Practitioners' Views". Journal of Medical Internet Research. 21 (3): e12802. doi:10.2196/12802. PMID 30892270. S2CID 59175658.
- Liyanage, Harshana; Liaw, Siaw-Teng; Jonnagaddala, Jitendra; Schreiber, Richard; Kuziemsky, Craig; Terry, Amanda L; de Lusignan, Simon (August 2019). "Artificial Intelligence in Primary Health Care: Perceptions, Issues, and Challenges: Primary Health Care Informatics Working Group Contribution to the Yearbook of Medical Informatics 2019". Yearbook of Medical Informatics. 28 (1): 041–046. doi:10.1055/s-0039-1677901. PMC 6697547. PMID 31022751.
- Blease, Charlotte; Kaptchuk, Ted J; Bernstein, Michael H; Mandl, Kenneth D; Halamka, John D; DesRoches, Catherine M (20 March 2019). "Artificial Intelligence and the Future of Primary Care: Exploratory Qualitative Study of UK General Practitioners' Views". Journal of Medical Internet Research. 21 (3): e12802. doi:10.2196/12802. PMID 30892270. S2CID 59175658.
- Kocaballi, A. Baki; Ijaz, Kiran; Laranjo, Liliana; Quiroz, Juan C.; Rezazadegan, Dana; Tong, Huong Ly; Willcock, Simon; Berkovsky, Shlomo; Coiera, Enrico (2020). "Envisioning an artificial intelligence documentation assistant for future primary care consultations: A co-design study with general practitioners". Journal of the American Medical Informatics Association. doi:10.1093/jamia/ocaa131. PMID 32845984.
- Jiang F, Jiang Y, Zhi H, Dong Y, Li H, Ma S, et al. (December 2017). "Artificial intelligence in healthcare: past, present and future". Stroke and Vascular Neurology. 2 (4): 230–243. doi:10.1136/svn-2017-000101. PMC 5829945. PMID 29507784.
- Alić B, Gurbeta L, Badnjević A (June 2017). "Machine learning techniques for classification of diabetes and cardiovascular diseases". 2017 6th Mediterranean Conference on Embedded Computing (MECO). IEEE: 1–4. doi:10.1109/meco.2017.7977152. ISBN 978-1-5090-6742-8. S2CID 22942669.
- Pacis D (February 2018). "Trends in telemedicine utilizing artificial intelligence". AIP Conference Proceedings. 1933 (1): 040009. Bibcode:2018AIPC.1933d0009P. doi:10.1063/1.5023979.
- "Artificial Intelligence | Types of AI | 7 Practical Usage of Artificial Intelligence". Talky Blog. 2019-07-12. Archived from the original on 17 July 2019. Retrieved 2019-07-27.
- "Remote or Wearable Patient Monitoring Devices EUAs". U.S. Food & Drug Administration. Retrieved 10 May 2020.
- Bennett, Casey C.; Selove, Rebecca; Doub, Thomas W. (April 2012). "EHRs Connect Research and Practice: Where Predictive Modeling, Artificial Intelligence, and Clinical Decision Support Intersect". Health Policy and Technology. 1 (2): 105–114. arXiv:1204.4927. doi:10.1016/j.hlpt.2012.03.001. S2CID 25022446 – via ResearchGate.
- Bokharaeian B, Diaz A, Chitsaz H (2016). "Enhancing Extraction of Drug-Drug Interaction from Literature Using Neutral Candidates, Negation, and Clause Dependency". PLOS ONE. 11 (10): e0163480. Bibcode:2016PLoSO..1163480B. doi:10.1371/journal.pone.0163480. PMC 5047471. PMID 27695078.
- Cai R, Liu M, Hu Y, Melton BL, Matheny ME, Xu H, Duan L, Waitman LR (February 2017). "Identification of adverse drug-drug interactions through causal association rule discovery from spontaneous adverse event reports". Artificial Intelligence in Medicine. 76: 7–15. doi:10.1016/j.artmed.2017.01.004. PMC 6438384. PMID 28363289.
- Christopoulou F, Tran TT, Sahu SK, Miwa M, Ananiadou S (January 2020). "Adverse drug events and medication relation extraction in electronic health records with ensemble deep learning methods". Journal of the American Medical Informatics Association. 27 (1): 39–46. doi:10.1093/jamia/ocz101. PMC 6913215. PMID 31390003.
- Zhou D, Miao L, He Y (May 2018). "Position-aware deep multi-task learning for drug-drug interaction extraction" (PDF). Artificial Intelligence in Medicine. 87: 1–8. doi:10.1016/j.artmed.2018.03.001. PMID 29559249.
- García JS (2013-04-14). Optimización del tratamiento de enfermos pluripatológicos en atención primaria UCAMI HHUU Virgen del Rocio (Report). Sevilla. Spain – via ponencias de la II Reunión de Paciente Pluripatológico y Edad Avanzada Archived.
- Herrero-Zazo M, Segura-Bedmar I, Martínez P, Declerck T (October 2013). "The DDI corpus: an annotated corpus with pharmacological substances and drug-drug interactions". Journal of Biomedical Informatics. 46 (5): 914–20. doi:10.1016/j.jbi.2013.07.011. PMID 23906817.
- Segura Bedmar I, Martínez P, Herrero Zazo M (June 2013). Semeval-2013 task 9: Extraction of drug-drug interactions from biomedical texts (ddiextraction 2013). Second Joint Conference on Lexical and Computational Semantics. 2. Association for Computational Linguistics. pp. 341–350.
- Xu B, Shi X, Yin Y, Zhao Z, Zheng W, Lin H, Yang Z, Wang J, Xia F (May 2019). "Incorporating User Generated Content for Drug Drug Interaction Extraction Based on Full Attention Mechanism". IEEE Transactions on NanoBioscience. 18 (3): 360–7. doi:10.1109/TNB.2019.2919188. PMID 31144641. S2CID 169038906.
- Wakefield J (30 January 2020). "Artificial intelligence-created medicine to be used on humans for first time". BBC News.
- "Novel molecules designed by artificial intelligence in 21 days are validated in mice". EurekAlert!. 2 September 2019. Retrieved 5 September 2019.
- "Has AI Discovered a Drug Now? Guess". Science. 4 September 2019. Retrieved 5 September 2019.
- Zhavoronkov, Alex; Ivanenkov, Yan A.; Aliper, Alex; Veselov, Mark S.; Aladinskiy, Vladimir A.; Aladinskaya, Anastasiya V.; Terentiev, Victor A.; Polykovskiy, Daniil A.; Kuznetsov, Maksim D.; Asadulaev, Arip; Volkov, Yury; Zholus, Artem; Shayakhmetov, Rim R.; Zhebrak, Alexander; Minaeva, Lidiya I.; Zagribelnyy, Bogdan A.; Lee, Lennart H.; Soll, Richard; Madge, David; Xing, Li; Guo, Tao; Aspuru-Guzik, Alán (2 September 2019). "Deep learning enables rapid identification of potent DDR1 kinase inhibitors". Nature. 37 (9): 1038–1040. doi:10.1038/s41587-019-0224-x. PMID 31477924. S2CID 201716327.
- "Deep Genomics Nominates Industry's First AI-Discovered Therapeutic Candidate". Deep Genomics. 25 September 2019. Retrieved 25 September 2019.
- La Monica PR (8 March 2018). "What merger mania means for health care". CNNMoney. Retrieved 2018-04-11.
- Leaf C (19 March 2019). "Why You're the Reason For Those Health Care Mergers". Fortune. Retrieved 2018-04-10.
- Horvitz EJ, Breese JS, Henrion M (July 1988). "Decision theory in expert systems and artificial intelligence". International Journal of Approximate Reasoning. 2 (3): 247–302. doi:10.1016/0888-613x(88)90120-x. ISSN 0888-613X.
- Arnold D, Wilson T (June 2017). "What Doctor? Why AI and robotics will define New Health" (PDF). PwC. Retrieved 8 October 2018.
- Cohn J (20 February 2013). "The Robot Will See You Now". The Atlantic. Retrieved 2018-10-26.
- Lorenzetti L (5 April 2016). "From Cancer to Consumer Tech: A Look Inside IBM's Watson Health Strategy". Fortune. Retrieved 2018-10-26.
- "IBM and Rensselaer Team to Research Chronic Diseases with Cognitive Computing".
- Bass D (20 September 2016). "Microsoft Develops AI to Help Cancer Doctors Find the Right Treatments". Bloomberg. Retrieved 2018-10-26.
- Knapton S (20 September 2016). "Microsoft will 'solve' cancer within 10 years by 'reprogramming' diseased cells". The Telegraph. Retrieved 2018-10-16.
- Bloch-Budzier S (22 November 2016). "NHS teams with Google to treat patients". BBC News. Retrieved 2018-10-16.
- Baraniuk C (31 August 2016). "Google gets access to cancer scans". BBC News. Retrieved 2018-10-16.
- Fannin R (23 August 2019). "Baidu, Alibaba, Tencent Clash To Lead China's Tech Future While A New 'B' Arises". Forbes.
- Lew L (11 February 2018). "How Tencent's medical ecosystem is shaping the future of China's healthcare". Tech Node.
- Primack D (26 May 2016). "Intel Capital Cancels $1 Billion Portfolio Sale". Fortune. Retrieved 2018-10-26.
- Crowley J (20 September 2019). "AI is transforming how radiologists detect breast cancers". The Sunday Times.
- Marandi R (October 15, 2019). "Indian AI startup in talks to raise $20m to fight tuberculosis". Nikkei Asian Review. Retrieved February 13, 2020.
- Ge C (12 July 2017). "Alibaba, Tencent see AI as solution". South China Morning Post.
- KareXpert Technologies Private Limited (23 April 2020). "AI-ready Telemedicine Digital Platform By KareXpert".
- Parkin S (9 March 2016). "The Artificially Intelligent Doctor Will Hear You Now". MIT Technology Review. Retrieved 14 April 2018.
- Garbuio M, Lin N (2019). "Artificial Intelligence as a Growth Engine for Health Care Startups: Emerging Business Models". California Management Review. 61 (2): 59–83. doi:10.1177/0008125618811931. S2CID 158219917.
- Jourdan A. "AI ambulances and robot doctors: China seeks digital salve to ease hospital strain". Reuters.
- Kong X, Ai B, Kong Y, Su L, Ning Y, Howard N, Gong S, Li C, Wang J, Lee WT, Wang J, Kong Y, Wang J, Fang Y (2019). "Artificial intelligence: a key to relieve China's insufficient and unequally-distributed medical resources". American Journal of Translational Research. 11 (5): 2632–2640. PMC 6556644. PMID 31217843.
- Nott G (24 January 2019). "Queensland Health continues robot hospital helper roll-out". Computerworld.
- "In focus: Mumbai-based Haptik which developed India's official WhatsApp chatbot for Covid-19". Hindustan Times Tech. Retrieved 2020-07-23.
- "India's Coronavirus Chatbot on WhatsApp Crosses 1.7 Crore Users in 10 Days". NDTV Gadgets 360. Retrieved 2020-07-23.
- Ahaskar, Abhijit (2020-03-27). "How WhatsApp chatbots are helping in the fight against Covid-19". Livemint. Retrieved 2020-07-23.
- Kurup, Rajesh. "COVID-19: Govt of India launches a WhatsApp chatbot". @businessline. Retrieved 2020-07-23.
- "Government of Maharashtra launches Aaple Sarkar chatbot with Haptik". The Economic Times. Retrieved 2020-07-23.
- Bresnick J (30 April 2018). "Top 12 Ways Artificial Intelligence Will Impact Healthcare". HealthITAnalytics.
- Chen AF, Zoga AC, Vaccaro AR (1 November 2017). "Point/Counterpoint: Artificial Intelligence in Healthcare". Healthcare Transformation. 2 (2): 84–92. doi:10.1089/heat.2017.29042.pcp.
- Price WN. "Artificial Intelligence in Health Care: Applications and Legal Issues". Petrie-Flom Center. Retrieved 2018-04-11.
- Felten E (3 May 2016). "Preparing for the Future of Artificial Intelligence". Whitehouse.gov.
- "The National Artificial Intelligence Research and Development Strategic Plan" (PDF). Office of Science and Technology Policy. 16 October 2016.
- "FDA Assembles Team to Oversee AI Revolution in Health". IEEE Spectrum: Technology, Engineering, and Science News. Retrieved 2018-04-04.
- "Focus Group on "Artificial Intelligence for Health"". International Telecommunication Union (ITU). Retrieved 2018-12-18.
- Ibaraki S. "$9T Global Healthcare Strengthened By ITU Focus Group AI For Health". Forbes. Retrieved 2018-12-18.
- "Artificial Intelligence for Health: ITU and WHO Call for Proposals – Fraunhofer Heinrich Hertz Institute". Fraunhofer-Institut für Nachrichtentechnik, Heinrich-Hertz-Institut, HHI. Retrieved 2018-12-18.
- Bennett CC, Doub TW, Selove R (June 2012). "EHRs connect research and practice: Where predictive modeling, artificial intelligence, and clinical decision support intersect". Health Policy and Technology. 1 (2): 105–14. arXiv:1204.4927. doi:10.1016/j.hlpt.2012.03.001. S2CID 25022446.
- Wahl B, Cossy-Gantner A, Germann S, Schwalbe NR (2018). "Artificial intelligence (AI) and global health: how can AI contribute to health in resource-poor settings?". BMJ Global Health. 3 (4): e000798. doi:10.1136/bmjgh-2018-000798. PMC 6135465. PMID 30233828.
- de Jesus A (21 November 2019). "Artificial Intelligence in Epidemiology". Emerj. AI Research and Advisory Company.
- "Accelerating America's Leadership in Artificial Intelligence". The White House. The United States Government. 11 February 2019.